Invention Grant
- Patent Title: Ketamine for treatment of ADNP syndrome and sensory processing deficits
-
Application No.: US16827521Application Date: 2020-03-23
-
Publication No.: US11571396B2Publication Date: 2023-02-07
- Inventor: Sandra Sermone , Matthew Davis
- Applicant: Sandra Sermone , Matthew Davis
- Applicant Address: US WA Brush Prairie; US WA Brush Prairie
- Assignee: Sandra Sermone,Matthew Davis
- Current Assignee: Sandra Sermone,Matthew Davis
- Current Assignee Address: US WA Brush Prairie; US WA Brush Prairie
- Main IPC: A61K31/135
- IPC: A61K31/135 ; A61P25/00
Abstract:
A method of treating sensory processing disorder, autism spectrum disorder, and/or ADNP syndrome comprising the administration of low doses of ketamine and/or low doses of ketamine and NAP.
Public/Granted literature
- US20200297662A1 KETAMINE FOR TREATMENT OF ADNP SYNDROME AND SENSORY PROCESSING DEFICITS Public/Granted day:2020-09-24
Information query
